|
1
|
Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh
KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, et al: Screening
for gastric cancer in Asia: Current evidence and practice. Lancet
Oncol. 9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang X, Xu X, Ma J, Xue X, Li Z, Deng P,
Zhang S, Zhi Y, Chen J and Dai D: NDRG1 expression is related to
the progression and prognosis of gastric cancer patients through
modulating proliferation, invasion and cell cycle of gastric cancer
cells. Mol Biol Rep. 41:6215–6223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McLemore MR: The role of the data safety
monitoring board: Why was the Avastin phase III clinical trial
stopped? Clin J Oncol Nurs. 10:153–154. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qu B, Guo L, Ma JL and Lv Y:
Antiangiogenesis therapy might have the unintended effect of
promoting tumor metastasis by increasing an alternative circulatory
system. Med Hypotheses. 74:360–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Maniotis AJ, Folberg R, Hess A, et
al: Vascular channel formation by human melanoma cells in vivo and
in vitro: Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW,
Che N, Wang XH, Du J, Liu YX and Sun BC: Expression and functional
significance of Twist1 in hepatocellular carcinoma: Its role in
vasculogenic mimicry. Hepatology. 51:545–556. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu TJ, Sun BC, Zhao XL, Zhao XM, Sun T,
Gu Q, Yao Z, Dong XY, Zhao N and Liu N: CD133+ cells with cancer
stem cell characteristics associates with vasculogenic mimicry in
triple-negative breast cancer. Oncogene. 32:544–553. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J,
Sun T, Wang J, Sun R and Liu Y: Hypoxia promotes vasculogenic
mimicry formation by inducing epithelial-mesenchymal transition in
ovarian carcinoma. Gynecol Oncol. 133:575–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun J, Sun B, Zhu D, Zhao X, Zhang Y, Dong
X, Che N, Li J, Liu F, Zhao N, et al: HMGA2 regulates CD44
expression to promote gastric cancer cell motility and sphere
formation. Am J Cancer Res. 7:260–274. 2017.PubMed/NCBI
|
|
10
|
Richardson A, Kovacevic Z and Richardson
DR: Iron chelation: Inhibition of key signaling pathways in the
induction of the epithelial mesenchymal transition in pancreatic
cancer and other tumors. Crit Rev Oncog. 18:409–434. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kovacevic Z, Menezes SV, Sahni S,
Kalinowski DS, Bae DH, Lane DJ and Richardson DR: The metastasis
suppressor, N-MYC downstream-regulated gene-1 (NDRG1),
down-regulates the ErbB family of receptors to inhibit downstream
oncogenic signaling pathways. J Biol Chem. 291:1029–1052. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun T, Sun BC, Zhao XL, Zhao N, Dong XY,
Che N, Yao Z, Ma YM, Gu Q, Zong WK and Liu ZY: Promotion of tumor
cell metastasis and vasculogenic mimicry by way of transcription
coactivation by Bcl-2 and Twist1: A study of hepatocellular
carcinoma. Hepatology. 54:1690–1706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Broggini T, Wustner M, Harms C, Stange L,
Blaes J, Thome C, Harms U, Mueller S, Weiler M, Wick W, et al:
NDRG1 overexpressing gliomas are characterized by reduced tumor
vascularization and resistance to antiangiogenic treatment. Cancer
Lett. 380:568–576. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bittner M, Meltzer P, Chen Y, Jiang Y,
Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, et
al: Molecular classification of cutaneous malignant melanoma by
gene expression profiling. Nature. 406:536–540. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rüschoff J, Dietel M, Baretton G, Arbogast
S, Walch A, Monges G, Chenard MP, Penault-Llorca F, Nagelmeier I,
Schlake W, et al: HER2 diagnostics in gastric cancer-guideline
validation and development of standardized immunohistochemical
testing. Virchows Arch. 457:299–307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang P, Li S, Aronow WS, Wang Z, Nair CK,
Xue N, Shen X, Chen C and Cosgrove D: Double contrast-enhanced
ultrasonography evaluation of preoperative Lauren classification of
advanced gastric carcinoma. Arch Med Sci. 7:287–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun B, Zhang S, Zhang D, Yin X, Wang S, Gu
Y and Wang Y: Doxycycline influences microcirculation patterns in
B16 melanoma. Exp Biol Med (Maywood). 232:1300–1307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO classification of tumours of the digestive system.
Fourth edition. IARC; France: 2010
|
|
21
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wöhrer SS, Raderer M and Hejna M:
Palliative chemotherapy for advanced gastric cancer. Ann Oncol.
15:1585–1595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng J, Xie HY, Xu X, Wu J, Wei XY, Su R,
Zhang W, Lv Z, Zheng S and Zhou L: NDRG1 as a biomarker for
metastasis, recurrence and of poor prognosis in hepatocellular
carcinoma. Cancer Lett. 310:35–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagai MA, Gerhard R, Fregnani JH, Nonogaki
S, Rierger RB, Netto MM and Soares FA: Prognostic value of NDRG1
and SPARC protein expression in breast cancer patients. Breast
Cancer Res Treat. 126:1–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ureshino H, Murakami Y, Watari K, Izumi H,
Kawahara A, Kage M, Arao T, Nishio K, Yanagihara K, Kinoshita H, et
al: N-myc downstream regulated gene 1 (NDRG1) promotes metastasis
of human scirrhous gastric cancer cells through epithelial
mesenchymal transition. PLoS One. 7:e413122012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hendrix MJ, Seftor EA, Meltzer PS, Gardner
LM, Hess AR, Kirschmann DA, Schatteman GC and Seftor RE: Expression
and functional significance of VE-cadherin in aggressive human
melanoma cells: Role in vasculogenic mimicry. Proc Natl Acad Sci
USA. 98:8018–8023. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JC, Chung LC, Chen YJ, Feng TH and
Juang HH: N-myc downstream-regulated gene 1 downregulates cell
proliferation, invasiveness, and tumorigenesis in human oral
squamous cell carcinoma. Cancer Lett. 355:242–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iqbal N and Iqbal N: Human epidermal
growth factor receptor 2 (HER2) in cancers: Overexpression and
therapeutic implications. Mol Biol Int. 2014:8527482014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Y, Liu Y, Guo R, Fu Y, Zhang Z, Zhang
P, Zhou P, Wang T, Huang T, Li X and Li C: The novel
dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells
by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling.
Sci Rep. 8:33982018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Menezes SV, Sahni S, Kovacevic Z and
Richardson DR: Interplay of the iron-regulated metastasis
suppressor NDRG1 with epidermal growth factor receptor (EGFR) and
oncogenic signaling. J Biol Chem. 292:12772–12782. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lei YY, Huang JY, Zhao QR, Jiang N, Xu HM,
Wang ZN, Li HQ, Zhang SB and Sun Z: The clinicopathological
parameters and prognostic significance of HER2 expression in
gastric cancer patients: A meta-analysis of literature. World J
Surg Oncol. 15:682017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu T, Sun B, Zhao X, Gu Q, Dong X, Yao Z,
Zhao N, Chi J, Liu N, Sun R and Ma Y: HER2/neu expression
correlates with vasculogenic mimicry in invasive breast carcinoma.
J Cell Mol Med. 17:116–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
